Most Popular

The Netherlands: SHS Capital acquires majority stake in Basic Pharma

Germany-based healthcare investor SHS Capital is acquiring a majority stake in Basic Pharma, a Dutch speciality pharmaceutical platform and full-service CDMO, providing a succession solution for the founder and in support of developing Basic Pharma into a leading European speciality pharma and dossier development platform for nasal sprays. Founded in...

UK: Sofinnova Partners appoints David Evans as partner in London

Sofinnova Partners, a France-based European venture capital firm in life sciences, has appointed David Evans as partner. He will invest as part of Sofinnova’s Crossover Strategy, its late stage private and public investment fund. The appointment also reinforces Sofinnova's senior partner presence in London as the firm continues to scale its growth strategy. Evans, a physician-scientist with deep pharma and drug development expertise, joins from the Roche Venture Fund, where he most recently served as senior investment director. His career spans frontline patient care as a doctor in Australia and...